Article
Dual-targeting strategy to repurpose Cetuximab with HFn nanoconjugates for immunotherapy…
medRxiv · 2025 · Barbieri, L.; Salvioni, L.; Banfi, A.; Garbujo, S.; Fiandra, L.; Baioni, C.; Giustra, M.; Morelli, L.; Frascotti, G.; Colombo, M.; Innocenti, M.; Prosperi, D.
Key facts
| Title | Dual-targeting strategy to repurpose Cetuximab with HFn nanoconjugates for immunotherapy of triple-negative breast cancer |
|---|---|
| First author | Barbieri, L.; Salvioni, L.; Banfi, A.; Garbujo, S.; Fiandra, L.; Baioni, C.; Giustra, M.; Morelli, L.; Frascotti, G.; Colombo, M.; Innocenti, M.; Prosperi, D. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.02.03.634255 |
| Devices mentioned | K040782 |
| Product codes mentioned | JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1